Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
A Phase Ib, Open-label, Multi-center Dose-finding Study of Oral Panobinostat (LBH589) in Combination With Ara-C and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Single Dose Study With 4SC-203 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen
- Status
- COMPLETED
- Phase
- PHASE1
Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.
- Status
- COMPLETED
- Phase
- PHASE1
Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia
- Status
- COMPLETED
- Phase
- PHASE2
High-dose Cytarabine and Survival in AML
- Status
- COMPLETED
- Phase
- N/A
A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients
- Status
- SUSPENDED
- Phase
- PHASE2
Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- NA
Study of Dosage Individualisation for the Treatment of Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- N/A
T-cell Depleted Alternative Donor Transplantation
- Status
- TERMINATED
- Phase
- PHASE2